CN1951962A - 用于制备抗肿瘤抗体的多肽及其应用 - Google Patents
用于制备抗肿瘤抗体的多肽及其应用 Download PDFInfo
- Publication number
- CN1951962A CN1951962A CNA2005101091314A CN200510109131A CN1951962A CN 1951962 A CN1951962 A CN 1951962A CN A2005101091314 A CNA2005101091314 A CN A2005101091314A CN 200510109131 A CN200510109131 A CN 200510109131A CN 1951962 A CN1951962 A CN 1951962A
- Authority
- CN
- China
- Prior art keywords
- antibody
- monoclonal antibody
- polypeptide
- tumour
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005101091314A CN1951962B (zh) | 2005-10-18 | 2005-10-18 | 用于制备抗肿瘤抗体的多肽及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005101091314A CN1951962B (zh) | 2005-10-18 | 2005-10-18 | 用于制备抗肿瘤抗体的多肽及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1951962A true CN1951962A (zh) | 2007-04-25 |
CN1951962B CN1951962B (zh) | 2012-01-18 |
Family
ID=38058533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005101091314A Expired - Fee Related CN1951962B (zh) | 2005-10-18 | 2005-10-18 | 用于制备抗肿瘤抗体的多肽及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1951962B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107573407A (zh) * | 2013-11-19 | 2018-01-12 | 中国科学院苏州纳米技术与纳米仿生研究所 | 多肽、其生产方法及用途 |
CN109705210A (zh) * | 2018-12-25 | 2019-05-03 | 深圳大学 | Oct4抗原表位肽、抗原偶联物及其制备方法和应用 |
-
2005
- 2005-10-18 CN CN2005101091314A patent/CN1951962B/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107573407A (zh) * | 2013-11-19 | 2018-01-12 | 中国科学院苏州纳米技术与纳米仿生研究所 | 多肽、其生产方法及用途 |
CN109705210A (zh) * | 2018-12-25 | 2019-05-03 | 深圳大学 | Oct4抗原表位肽、抗原偶联物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1951962B (zh) | 2012-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pastuskovas et al. | Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer model | |
CN106456766B (zh) | 抗免疫原性糖肽的抗体、包含其的组合物及其用途 | |
CN104093743B (zh) | 特异于her3的结合分子及其用途 | |
Reichert | Antibodies to watch in 2010 | |
CN105338977B (zh) | 艾日布林和乐伐替尼作为治疗癌症的联合疗法的用途 | |
CN106572993A (zh) | 用于治疗癌症的组合疗法 | |
CN107135654A (zh) | 巨胞饮人类抗cd46抗体和靶向癌症疗法 | |
CN107840891A (zh) | 高亲和力的抗msln抗体及其应用 | |
CN102741292B (zh) | 在治疗头和颈鳞状细胞癌中使用的cd44单克隆抗体 | |
EP3919081A1 (en) | Dosing regimens for anti-tf-antibody drug-conjugates | |
CN103030695A (zh) | 抗c-Met人源化抗体及含其的预防或治疗癌症用的药物组合物 | |
CN105764925A (zh) | 抗EpCAM抗体和使用方法 | |
JP2014500278A (ja) | 二重特異性scFvコンジュゲートの投薬量および投与 | |
CN104968684B (zh) | 新的抗体片段、组合物和其用途 | |
JP2017066156A (ja) | 前立腺癌治療のための抗アルファ−vインテグリン抗体 | |
CN1951962B (zh) | 用于制备抗肿瘤抗体的多肽及其应用 | |
CN104892763A (zh) | 抗体-药物偶联物Pertuzumab-MCC-DM1、其与Trastuzumab的组合物及其应用 | |
CN103417965B (zh) | 一种含有抗vegf抗体的药物组合物 | |
CN1933851B (zh) | 使用抗-α5β1抗体抑制癌细胞增殖 | |
CN101497662B (zh) | 用于制备抗肿瘤抗体的tm4sf3蛋白及其应用 | |
Wagner et al. | Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine | |
CN101962405A (zh) | 一种人源乳腺癌抗原及其抗体 | |
CN1972712A (zh) | 用胞外拮抗物和胞内拮抗物抑制受体酪氨酸激酶的方法 | |
CN101525385B (zh) | 恶性淋巴瘤、自身免疫性疾病抗体药物的筛选及其制备方法和用途 | |
KR101637689B1 (ko) | 아토르바스타틴을 유효성분으로 포함하는 항체의 종양 침투력 증진용 조성물 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: TUMOUR INST., CHINESE MEDICAL ACADEMY Free format text: FORMER OWNER: TUMAR INST OF TUMOOR HOSPITAL, CHINESE ACADEMY OF MEDICAL SCIENCES Effective date: 20090807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090807 Address after: Postal code 17, South Lane, Panjiayuan, Beijing, 100021: Chaoyang District Applicant after: Tumour Inst., China Medical Science Research Academy Address before: Postal code 17, South Lane, Panjiayuan, Beijing, 100021: Chaoyang District Applicant before: Tumour Research Inst. under Tumour Hospital of Chinese Academy of medical scienc |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120118 Termination date: 20141018 |
|
EXPY | Termination of patent right or utility model |